MX9203751A - Compuestos de arilo disubstituido que exhiben actividad antagonista selectiva de leucotrieno b4. - Google Patents
Compuestos de arilo disubstituido que exhiben actividad antagonista selectiva de leucotrieno b4.Info
- Publication number
- MX9203751A MX9203751A MX9203751A MX9203751A MX9203751A MX 9203751 A MX9203751 A MX 9203751A MX 9203751 A MX9203751 A MX 9203751A MX 9203751 A MX9203751 A MX 9203751A MX 9203751 A MX9203751 A MX 9203751A
- Authority
- MX
- Mexico
- Prior art keywords
- leucotrene
- antagonist activity
- aryl compounds
- selective antagonist
- disubstituted aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/586,830 US5210208A (en) | 1990-09-24 | 1990-09-24 | Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9203751A true MX9203751A (es) | 1992-09-01 |
Family
ID=24347270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9203751A MX9203751A (es) | 1990-09-24 | 1992-06-29 | Compuestos de arilo disubstituido que exhiben actividad antagonista selectiva de leucotrieno b4. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5210208A (es) |
EP (1) | EP0554313B1 (es) |
JP (1) | JP3368565B2 (es) |
AT (1) | ATE126205T1 (es) |
AU (1) | AU650825B2 (es) |
CA (1) | CA2092306C (es) |
DE (1) | DE69112074T2 (es) |
MX (1) | MX9203751A (es) |
WO (1) | WO1992005145A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3334087B2 (ja) * | 1990-09-10 | 2002-10-15 | アヴェンティス ファーマシューティカルズ インコーポレイテッド | 選択的ロイコトリエンb▲4▼拮抗剤活性を示す置換された二環式アリール化合物 |
JPH0741421A (ja) * | 1993-05-28 | 1995-02-10 | Suntory Ltd | ロイコトリエンb4 (ltb4 )による医学的症状の予防及び改善剤 |
FR2705959B1 (fr) * | 1993-06-01 | 1995-08-11 | Oreal | Procédé de synthèse stéréospécifique de leucotriène B4 sous sa configuration 6Z, 8E, 10E et produits intermédiaires. |
EP0833664A1 (en) | 1995-06-12 | 1998-04-08 | G.D. SEARLE & CO. | Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations |
AU2250097A (en) * | 1996-02-13 | 1997-09-02 | G.D. Searle & Co. | Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist |
EP0942903A1 (en) | 1996-09-26 | 1999-09-22 | Novartis AG | Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity |
SE0104334D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
GB0314079D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
GB0229931D0 (en) * | 2002-12-21 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
JP5148610B2 (ja) | 2006-07-24 | 2013-02-20 | ビーエーエスエフ ソシエタス・ヨーロピア | アゾリルメチルオキシラン、植物病原菌類を防除するためのその使用、およびそれを含む薬剤 |
WO2008012234A2 (de) | 2006-07-25 | 2008-01-31 | Basf Se | Azolylmethyloxirane, ihre verwendung zur bekämpfung von pflanzenpathogenen pilzen sowie sie enthaltende mittel |
US7994340B2 (en) | 2006-12-22 | 2011-08-09 | Basf Se | Azolylmethyloxiranes, their use for controlling phytopathogenic fungi, and compositions comprising them |
US9079880B2 (en) | 2010-07-07 | 2015-07-14 | Boehringer Ingelheim International Gmbh | Rho kinase inhibitors |
US8697911B2 (en) | 2010-07-07 | 2014-04-15 | Boehringer Ingelheim International Gmbh | Rho kinase inhibitors |
EP2630144B1 (en) | 2010-10-19 | 2016-09-07 | Boehringer Ingelheim International GmbH | Rho kinase inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4191824A (en) * | 1976-02-04 | 1980-03-04 | The Upjohn Company | 5-Halo PGI compounds |
US4216238A (en) * | 1979-02-13 | 1980-08-05 | Stauffer Chemical Company | Dialkyl amino ethyl amides, their salts and their use as anti-ripening agents |
US4727180A (en) * | 1979-07-26 | 1988-02-23 | E. I. Du Pont De Nemours And Company | Antihypertensive polyhalohydroxylisopropyl phenylalkanoic and phenylalkenoic acids, amides and esters and intermediates thereto |
US5140046A (en) * | 1985-04-03 | 1992-08-18 | Yamanouchi Pharmaceutical Co., Ltd. | Phenylene derivatives, compositions and use |
US4820722A (en) * | 1987-08-14 | 1989-04-11 | Eli Lilly And Company | Disubstituted tetrazoles and their use as leukotriene antagonists |
-
1990
- 1990-09-24 US US07/586,830 patent/US5210208A/en not_active Expired - Lifetime
-
1991
- 1991-09-06 DE DE69112074T patent/DE69112074T2/de not_active Expired - Lifetime
- 1991-09-06 AU AU87610/91A patent/AU650825B2/en not_active Expired
- 1991-09-06 EP EP91918695A patent/EP0554313B1/en not_active Expired - Lifetime
- 1991-09-06 CA CA002092306A patent/CA2092306C/en not_active Expired - Lifetime
- 1991-09-06 AT AT91918695T patent/ATE126205T1/de not_active IP Right Cessation
- 1991-09-06 WO PCT/US1991/006446 patent/WO1992005145A1/en active IP Right Grant
- 1991-09-06 JP JP51785191A patent/JP3368565B2/ja not_active Expired - Lifetime
-
1992
- 1992-06-29 MX MX9203751A patent/MX9203751A/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CA2092306C (en) | 2004-11-16 |
JPH06502164A (ja) | 1994-03-10 |
EP0554313B1 (en) | 1995-08-09 |
EP0554313A4 (en) | 1994-05-18 |
US5210208A (en) | 1993-05-11 |
JP3368565B2 (ja) | 2003-01-20 |
CA2092306A1 (en) | 1992-03-25 |
EP0554313A1 (en) | 1993-08-11 |
DE69112074D1 (de) | 1995-09-14 |
AU8761091A (en) | 1992-04-15 |
ATE126205T1 (de) | 1995-08-15 |
AU650825B2 (en) | 1994-06-30 |
DE69112074T2 (de) | 1996-01-11 |
WO1992005145A1 (en) | 1992-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9203751A (es) | Compuestos de arilo disubstituido que exhiben actividad antagonista selectiva de leucotrieno b4. | |
ATE235906T1 (de) | Substituierte phenylpyrimidine derivate, für die behandlung oder prevention von zns-erkrankungen | |
IT9020055A0 (it) | Metodo per il mascheramento del sapore di farmaci | |
NO904694D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
KR920701466A (ko) | 면역조절 장애 치료를 위한 제약학적 생성물 | |
FR2387220A1 (fr) | Derives du benzimidazole et medicaments qui en contiennent | |
NL970023I1 (nl) | Medicamenten voor behandeling van oogontsteking. | |
DE68907423D1 (de) | Behandlung der akne. | |
FI953899A (fi) | Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi | |
EP0538416A4 (en) | Substituted monocyclic aryl compounds exhibiting selective leukotriene b 4? antagonist activity | |
NO864130L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater. | |
NO883122L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater. | |
ES2058343T3 (es) | Piridinas disubstituidas. | |
FI891986A (fi) | Farmaceutiska sammansaettningar foer behandling av psoriasis. | |
EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
NO892505D0 (no) | Behandling av vandige dispersjoner. | |
NO913117L (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
DE3770718D1 (de) | P-hydroxyzimtamid derivate und diese enthaltende melanininhibitoren. | |
DK229984D0 (da) | 4-oxothiazolidin-2-yliden-acetamid-derivater | |
NO905327D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive karbamoylderivater. | |
NO862390D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater. | |
IT8619382A0 (it) | Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale. | |
DK382A (da) | Antiallergiske imidodisulfamider. | |
NO900972D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
ATE74505T1 (de) | Schmerzpraeparat. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |